New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
06:33 EDTVICL
theflyonthewall.com: Vical completes final patient follow-up in TransVAX CMV
Vical Incorporated announced that the company has completed the last scheduled follow-up visit for the final patient enrolled in a Phase 2 trial of its TransVax cytomegalovirus vaccine in hematopoietic stem cell transplant recipients. The company expects to have data available in the first half of 2010. :theflyonthewall.com



News For VICL From The Last 14 Days
Check below for free stories on VICL the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2010
10:54 EDTVICL
theflyonthewall.com: Vical management to meet with Needham

Subscribe for More Information
:theflyonthewall.com
06:33 EDTVICL
theflyonthewall.com: Vical completes enrollment in Allovectin-7 Phase lll Melanoma trial
Vical Incorporated announced that the company has completed enrollment of the planned 375 subjects in its multinational Phase 3 trial of Allovectin-7(R) in patients with metastatic melanoma. Allovectin-7(R) is a novel gene-based immunotherapeutic with a unique mechanism of action that is fundamentally different from currently approved treatments, and has the potential to be the first new primary treatment approved for metastatic melanoma in nearly 20 years. :theflyonthewall.com

January 26, 2010
06:36 EDTVICL
theflyonthewall.com: Vical to present an overview of its DNA vaccine and adjuvant technologies
Vical announced that the company will present an overview of its DNA vaccine and adjuvant technologies and an update on its clinical-stage vaccine development programs at the Phacilitate Vaccine Forum. :theflyonthewall.com